Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Brian Fiske
AddedMar 31, 2024
UpdatedMay 31, 2026
Brian Fiske

Brian Fiske

Board Member, Alix Ventures

CrunchbaseLinkedIn

Brian Fiske's Career

Alix Ventures
Alix Ventures

San Francisco, CA, US

Board Member· Board
Mythic Therapeutics
Mythic Therapeutics

Waltham, MA, US

Co-Founder

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Brian Fiske's Career

Alix Ventures
Alix Ventures
Investment Firm82019San Francisco, CA, US
Board Member· Board

Leadership at Alix Ventures

Jessica ChaoJessica ChaoBoard Member
Kamal ObbadKamal ObbadCo-Founder
Chas PulidoChas PulidoCo-Founder

Similar to Alix Ventures

Align VenturesAlign VenturesNew York City, NY, USest. 2013Align VenturesNew York City, NY, US · est. 2013

Align Ventures LLC: A New York-based venture capital firm specializing in the life science industry.

6
Avalon BioVenturesAvalon BioVenturesLos Angeles, CA, USest. 2013Avalon BioVenturesLos Angeles, CA, US · est. 2013

Avalon BioVentures: A biotech venture capital firm advancing breakthrough therapeutics.

4
Endpoint VenturesEndpoint VenturesSan Francisco, CA, USest. 2015Endpoint VenturesSan Francisco, CA, US · est. 2015

Early-stage investment firm specializing in healthcare, life sciences, diagnostics, and therapeutics.

2
Alira Health VenturesAlira Health VenturesFramingham, MA, USest. 1999Alira Health VenturesFramingham, MA, US · est. 1999

Global healthcare advisory firm driving innovation for life science companies.

$133M691
Mythic Therapeutics
Mythic Therapeutics
$126.6M462017Waltham, MA, US
Co-Founder

Leadership at Mythic Therapeutics

Alex NicholsAlex NicholsCo-Founder
Nimish GeraNimish GeraCo-Founder

Similar to Mythic Therapeutics

Adcentrx TherapeuticsAdcentrx TherapeuticsSan Diego, CA, USTherapeuticsest. 2021Adcentrx TherapeuticsSan Diego, CA, US · est. 2021

Adcentrx Therapeutics: Pioneering protein conjugate therapeutics for cancer and life-threatening diseases.

$101M31
PanTher TherapeuticsPanTher TherapeuticsWatertown, MA, USCancer Treatmentest. 2016PanTher TherapeuticsWatertown, MA, US · est. 2016

PanTher Therapeutics: Revolutionizing cancer care with an effective, minimal side-effect treatment platform.

$21.3M13
Mersana TherapeuticsMersana TherapeuticsCambridge, MA, USOncology Agentsest. 2001Mersana TherapeuticsCambridge, MA, US · est. 2001

Mersana Therapeutics, a US-based company, specializes in producing novel oncology agents for cancer treatment.

Public · $655.6M228
Fortis TherapeuticsFortis TherapeuticsSan Diego, CA, USAntibody Drug Therapiesest. 2016Fortis TherapeuticsSan Diego, CA, US · est. 2016

Fortis Therapeutics, a biotech firm, develops innovative antibody drug therapies for advanced cancers.

$58M75

People Similar to Brian Fiske

Lau Eng BoonLau Eng BoonBoard Member · BukalapakJay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakSoemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakNugroho HerucahyonoNugroho HerucahyonoCo-Founder · BukalapakAchmad ZakyAchmad ZakyCo-Founder · BukalapakChi-hyung SongChi-hyung SongBoard Member · DunamuHaeil YiHaeil YiCo-Founder · DunamuHyoung-nyon KimHyoung-nyon KimCo-Founder · DunamuDave FickDave FickFounder · MythicPete HawleyPete HawleyCo-Founder · Red Robot LabsJohn LindenJohn LindenCo-Founder · Planet AlumniFrederick SooFrederick SooCo-Founder · NautoNick WhiteheadNick WhiteheadCo-Founder · Myosana TherapeuticsClint KiskerClint KiskerCo-Founder · Madison Wells Media